Common GLP-1 Side Effects and Practical Ways to Manage Them

Introduction

Glucagon-like peptide-1 (GLP-1) medications are gaining popularity for their benefits for type-2-diabetes and weight management¹. As their use continues to grow, there is also increasing interest in understanding potential GLP-1 side effects and how they may affect daily life. While these medicines are generally safe, many people have reported some side effects¹, especially during the early stages of treatment². Understanding what to expect may help people use these drugs more easily and confidently. In this blog, we will explore more about GLP-1 medications, such as their common GLP-1 agonist side effects, why they occur, and practical ways to manage them effectively. 

What Are GLP-1 Drugs?

Glucagon-like peptide-1 (GLP-1) is a naturally occurring hormone in the intestines that regulates blood glucose levels, slows stomach emptying, and promotes a sense of fullness after eating³. GLP-1 drugs are medications that mimic the action of this hormone, such as: 

• Release insulin when blood glucose rises (helping control blood glucose levels) 
• Reduce the amount of glucose released by the liver 
• Slow stomach emptying 
• Increase feelings of fullness and reduce appetite¹

Therefore, these are also called GLP-1 agonists. The common types include semaglutide, liraglutide, dulaglutide, and tirzepatide. These are commonly used to treat diabetes and to manage weight/ obesity (especially in those with diabetes)¹

Why Do GLP-1 Side Effects Occur?

Most GLP-1 agonist side effects occur because these medications change how the digestive system and appetite-regulating pathways work. The causes of GLP-1 agonist side effects include: 

• Slower Digestion: One of the main actions of GLP-1 medications is slowing the movement of food from the stomach into the intestines. This helps people feel full for longer and can reduce calorie intake, which supports weight loss and blood glucose control. However, because food remains in the stomach for a longer time, the occurrence of digestive symptoms and a feeling of fullness even after eating small portions of food may increase¹.
• Changes in Appetite Signals: GLP-1 medicines also have an effect on brain areas responsible for appetite and fullness. They help reduce appetite and make people feel full sooner during meals, contributing to side effects such as decreased desire to eat¹.

GLP-1 side effects are more noticeable at certain times: 

• Initial Treatment Phase: During this period, the body is suddenly adjusting to changes in digestion and appetite regulation caused by GLP-1 medication, contributing to several gastrointestinal side effects². 
• Dose Increase: GLP-1 medications are usually started at a low dose and gradually increased. Each dose increase strengthens the medication’s effects, which can temporarily make side effects more noticeable⁴. 
• Large Meals: As GLP-1 agonists slow stomach emptying, eating large portions can make the stomach feel overly full, causing side effects such as vomiting or nausea⁵. 

Common GLP-1 Side Effects

Most patients who take GLP-1 drugs tolerate them well; however, side effects might occur, particularly during the first few weeks of treatment or following a dosage increase. In most situations, these symptoms are mild to moderate and improve as the body adapts. Some common GLP-1 analogues side effects include: 

• Nausea: This is known to be the most common gastro-intestinal (GI) side effect of GLP-1 agonist drugs. According to some studies⁵, it usually affects 15% to 50% of people using the drugs. It is mainly seen during the first 4-5 weeks of the treatment and during dose escalation phases. Symptoms are usually mild and may resolve within a week⁵.
• Vomiting: Although less frequent compared to nausea, this GI side effect is also seen in about 5-20% of people using the medication. It can range from mild to moderate and mostly resolve within a week. In more severe cases, vomiting might cause symptoms like dehydration  and  electrolyte  imbalance⁵.
• Constipation: This is a less known GI side effect of GLP-1 agonists, affecting only 4-12% of drug users. However, it is more prevalent in patients with obesity (25-35%). Studies⁵ also show that constipation happens more often in overweight or obese people than in people with type 2 diabetes. It usually occurs during the first 16 weeks of treatment, specifically during the first 28 days. It tends to last longer as compared to other GI side effects⁵.
• Diarrhoea: This is seen in about 5-25% of people taking medication. It is known to start during the first four weeks of treatment and then decrease with time. Symptoms can last for about 3 days, particularly in people with obesity. It can also get worse in people who are already taking metformin or some other medications⁵.
• Abdominal Pain: Abdominal pain, discomfort or swelling is also seen in people. These range from mild to moderate⁶. While in most people it may not cause severe issues, persistent and severe cases should not be ignored, as they can be related to major GLP-1 agonist-associated adverse events, such as pancreatitis and gallstones⁷. 
• Bloating: It occurs as food remains in the stomach longer. This can occur even after eating relatively small meals and may be accompanied by mild discomfort or pressure in the abdomen¹. 
• Reduced Appetite: Although this is one of the expected outcomes of GLP-1 therapy, some individuals may find it difficult to consume enough calories or maintain balanced nutrition if appetite suppression becomes too strong¹.
• Fatigue: It is seen in many people using GLP-1 medications, mainly due to blood glucose drop or fluctuations, reduced food intake, or dehydration (from diarrhoea) rather than being directly associated with the medicine⁷.
• Headaches: Headaches or migraines (which might worsen) are reported by some people during the treatment phase. However, it requires more research to understand how often this happens⁸. Sometimes it can also be due to dehydration or related to other GI side effects. 
• Skin Reactions: Reactions such as mild itching or rashes are also reported as a GLP-1 agonist side effect (for injectable types). In rare cases, serious skin reactions, such as swelling under the skin (angioedema), eczema, or rare blistering skin conditions (bullous pemphigoid) are also reported⁹. 

Tips to Manage GLP-1 Side Effects

A few lifestyle changes that may help you manage GLP-1 side effects include: 

1. Eat Smaller, More Frequent Meals

The drug may have side effects such as nausea and vomiting¹. Try eating smaller portions spread throughout the day instead of eating large meals⁴. This helps reduce pressure on the stomach, making the symptoms less aggressive. 

2. Choose Light and Low-Fat Foods

Opt for simple, easy-to-digest meals such as soups, fruits, vegetables, lean proteins, and whole grains over fatty, fried, and heavily processed foods⁴, as they may take longer to digest and can worsen side effects.

3. Stay Well-Hydrated

Diarrhoea is a GI side effect of GLP-1 medications; therefore, drinking water might help maintain proper hydration needed by the body. However, in severe cases of dehydration, expert-guided oral intravenous rehydration solutions may be needed⁵. 

4. Avoid Eating Right Before Bed

Lying down soon after meals can cause acid reflux. Eating food 2-3 hours before bed may help reduce this. 

5. Increase Fibre Gradually

As the drug can cause constipation¹, introducing foods rich in fibre such as fruits, vegetables, and wholegrains might help lower the symptoms by supporting digestion¹⁰. 

6. Follow Prescribed Dosing Schedule

Dose changes may contribute to side effects; therefore, stick to the dosing pattern prescribed by the doctor to avoid inadvertent adverse effects of dose change⁴.

7. Avoid Lying Down Immediately After Eating

Always sit upright for some time after eating food to avoid side effects such as acid reflux and vomiting. 

Note: The information provided here is meant for general educational purposes only and is not intended to be medical advice. GLP-1 side effects and treatment can vary from person to person. Always follow the doctor’s instructions for diet, medication use, and dose schedule. Consult a doctor right away if your symptoms worsen and are no longer manageable at home. 

Managing Weight Loss and Appetite Changes

Weight loss and appetite reduction are the expected outcomes of GLP-1 medications³, but it is important to lose weight in a healthy manner. You can follow these precautions to achieve continued weight loss in a healthy manner. 

• Focus on consuming nutrient-dense foods (for example, fruits, vegetables, whole grains, and lean protein) even when you have less appetite. 
• Avoid skipping meals completely, as this can lead to low blood glucose and cause symptoms like fatigue and dizziness⁷. 
• Eat small, balanced meals, which can help maintain energy levels while supporting healthy weight loss. Improper food intake can also make the body nutrient deficit. In such cases, increase meal nutrient density rather than just portion sizes. 
• Aim for regular physical activity to help preserve muscle mass, improve overall health, and support long-term weight management¹¹. 

When to Consult a Doctor?

Seek medical attention for the following signs and symptoms: 

• Severe or persistent vomiting 
• Severe abdominal pain 
• Unexplained weakness or tiredness¹
• Severe diarrhoea or constipation that lasts many days⁵
• Signs of dehydration (severe thirst, dark urine, and dizziness) 
• Blurred vision or mood changes 
• Increased heartbeat 
• Symptoms of an allergic reaction, such as itching, rashes, swelling in the face, lips, tongue, or throat, or difficulty breathing⁷

Also Read: GLP-1 Diet Plan: Foods to Eat, Avoid, Meal Plans & More! 

Conclusion

GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment. 

These symptoms typically improve as the body adjusts to the drug. Eating small and frequent meals, staying hydrated, eating well-balanced meals, and sticking to the suggested medicine dosage can all help with symptom management. However, consulting a doctor is very important in case of severe or persistent side effects. 

Frequently Asked Questions (FAQs)

References

1. Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. 2024. https://www.ncbi.nlm.nih.gov/books/NBK551568/ 

2. Kim JA, Yoo HJ. Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning. Diabetes Metab J. 2025;49(4):525-541. doi:10.4093/dmj.2025.0242 https://pmc.ncbi.nlm.nih.gov/articles/PMC12270588/

3. Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Molecular Metabolism. 2019;30:72-130. doi:10.1016/j.molmet.2019.09.010 https://pubmed.ncbi.nlm.nih.gov/31767182/

4. Jain AB, Ali A, Gorgojo Martínez JJ, et al. Switching between GLP‐1 receptor agonists in clinical practice: Expert consensus and practical guidance. Int J Clin Pract. 2021;75(2). doi:10.1111/ijcp.13731 https://pubmed.ncbi.nlm.nih.gov/32975890/

5. Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. JCM. 2022;12(1):145. doi:10.3390/jcm12010145 https://pubmed.ncbi.nlm.nih.gov/36614945/

6. Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q. Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Front Public Health. 2022;10:996179. doi:10.3389/fpubh.2022.996179 https://pubmed.ncbi.nlm.nih.gov/36339230/

7. Medication Guide WEGOVY ® (wee-GOH-vee) (semaglutide) injection, for Subcutaneous Use. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256Orig1s006lbl.pdf 

8. J Modestino E, Bowirrat A, Lewandrowski3 KU, et al. Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss. Act Scie Neuro. Published online May 1, 2024:12-18. doi:10.31080/ASNE.2024.07.0731 https://pmc.ncbi.nlm.nih.gov/articles/PMC11309767/

9. Persson C, Eaton A, Mayrovitz HN. A Closer Look at the Dermatological Profile of GLP-1 Agonists. Diseases. 2025;13(5):127. doi:10.3390/diseases13050127 https://pubmed.ncbi.nlm.nih.gov/40422559/

10. Harvard T.H. Chan School of Public Health. Fiber. In: The Nutrition Source [Internet]. Boston (MA): Harvard T.H. Chan School of Public Health; [cited 2026 Jun 23]. Available from: https://nutritionsource.hsph.harvard.edu/carbohydrates/fiber/ 

11. Lundgren JR, Janus C, Jensen SBK, et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. N Engl J Med. 2021;384(18):1719-1730. doi:10.1056/NEJMoa2028198 https://www.nejm.org/doi/full/10.1056/NEJMoa2028198

12. Xie X, Yang S, Deng S, Liu Y, Xu Z, He B. Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis. Front Pharmacol. 2025;16:1613610. doi:10.3389/fphar.2025.1613610 https://pubmed.ncbi.nlm.nih.gov/41050409/

13. Berg S, Stickle H, Rose SJ, Nemec EC. Discontinuing glucagon‐like peptide‐1 receptor agonists and body habitus: A systematic review and meta‐analysis. Obesity Reviews. 2025;26(8):e13929. doi:10.1111/obr.13929 https://pubmed.ncbi.nlm.nih.gov/40186344/

Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.

Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.